Nadja Zeltner

Dr. Nadja Zeltner


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Stem Cell Reports
Verified
Journal Article
Open access
KSKenyi Saito-Diaz
Kenyi Saito-Diaz
JSJonathan Roy Street
Jonathan Roy Street
HUHeidi Ulrichs
Heidi Ulrichs
NZNadja Zeltner
Nadja Zeltner
The three peripheral sensory neuron (SN) subtypes, nociceptors, mechanoreceptors, and proprioceptors, localize to dorsal root ganglia and convey sensations such as pain, temperature, pressure, and limb movement/position. Despite previous reports, to date no protocol is available allowing the generation of all three SN subtypes at high efficiency and purity from human pluripotent stem cells (hPSCs). We describe a chemically defined differentiation protocol that generates all three SN subtypes from the same starting population, as well as methods to enrich for each individual subtype. The protocol yields high efficiency and purity cultures that are electrically active and respond to specific stimuli. We describe their molecular character and maturity stage and provide evidence for their use as an axotomy model; we show disease phenotypes in hPSCs derived from patients with familial dysautonomia. Our protocol will allow the modeling of human disorders affecting SNs, the search for treatments, and the study of human development.

22 May 2024 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
BHBeth A. Habecker
Beth A. Habecker
DBDonald Bers
Donald Bers
SBSusan J. Birren
Susan J. Birren
RCRui Chang
Rui Chang
NHNeil Herring
Neil Herring
DPDavid J. Paterson
David J. Paterson

17 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HWHsueh-Fu Wu
Hsueh-Fu Wu
WYWenxin Yu
Wenxin Yu
KSKenyi Saito-Diaz
Kenyi Saito-Diaz
CHChia-Wei Huang
Chia-Wei Huang
JCJoseph Carey
Joseph Carey
NZNadja Zeltner
Nadja Zeltner
Familial dysautonomia (FD), a rare neurodevelopmental and neurodegenerative disorder affects the sympathetic and sensory nervous system. Although almost all patients harbor a mutation in ELP1, it remains unresolved exactly how function of sympathetic neurons (symNs) is affected; knowledge critical for understanding debilitating disease hallmarks, including cardiovascular instability or dysautonomic crises, that result from dysregulated sympathetic activity. Here, we employ the human pluripotent stem cell (hPSC) system to understand symN disease mechanisms and test candidate drugs. FD symNs are intrinsically hyperactive in vitro, in cardiomyocyte co-cultures, and in animal models. We report reduced norepinephrine transporter expression, decreased intracellular norepinephrine (NE), decreased NE re-uptake, and excessive extracellular NE in FD symNs. SymN hyperactivity is not a direct ELP1 mutation result, but may connect to NET via RAB proteins. We found that candidate drugs lowered hyperactivity independent of ELP1 modulation. Our findings may have implications for other symN disorders and may allow future drug testing and discovery.

11 April 2024 in Cell Stem Cell
Verified
Journal Article
Closed access
HWHsueh-Fu Wu
Hsueh-Fu Wu
KSKenyi Saito-Diaz
Kenyi Saito-Diaz
CHChia-Wei Huang
Chia-Wei Huang
JMJessica L. McAlpine
Jessica L. McAlpine
DSDong Eun Seo
Dong Eun Seo
NZNadja Zeltner
Nadja Zeltner

24 May 2020 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
HWHsueh Fu Wu
Hsueh Fu Wu
NZNadja Zeltner
Nadja Zeltner
Human pluripotent stem cells (hPSCs) have become a powerful tool for disease modeling and the study of human embryonic development in vitro. We previously presented a differentiation protocol for the derivation of autonomic neurons with sympathetic character that has been applied to patients with autonomic neuropathy. However, the protocol was built on Knock Out Serum Replacement (KSR) and feeder-based culture conditions, and to ensure high differentiation efficiency, cell sorting was necessary. These factors cause high variability, high cost, and low reproducibility. Moreover, mature sympathetic properties, including electrical activity, have not been verified. Here, we present an optimized protocol where PSC culture and differentiation are performed in feeder-free and chemically defined culture conditions. Genetic markers identifying trunk neural crest are identified. Further differentiation into postganglionic sympathetic neurons is achieved after 20 days without the need for cell sorting. Electrophysiological recording further shows the functional neuron identity. Firing detected from our differentiated neurons can be enhanced by nicotine and suppressed by the adrenergic receptor antagonist propranolol. Intermediate sympathetic neural progenitors in this protocol can be maintained as neural spheroids for up to 2 weeks, which allows expansion of the cultures. In sum, our updated sympathetic neuron differentiation protocol shows high differentiation efficiency, better reproducibility, more flexibility, and better neural maturation compared to the previous version. This protocol will provide researchers with the cells necessary to study human disorders that affect the autonomic nervous system.